# Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans

> **NCT02800408** · NA · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 10 (actual)

## Conditions studied

- β-cryptoxanthin Bioavailability From Biofortified Maize in Humans

## Interventions

- **OTHER:** Whole grain high-BCX maize
- **OTHER:** Refined grain high-BCX maize
- **OTHER:** Whole grain white maize

## Key facts

- **NCT ID:** NCT02800408
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-21
- **Primary completion:** 2016-11-14
- **Final completion:** 2017-10-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-01-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02800408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02800408, "Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02800408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*